Keith Martin at the Health Committee

Thank you, Madam Chair. I'll share my time with Ms. Murray.

Thank you all for being here. This probably seems like old times for you once again.

I have three quick questions for Dr. Butler-Jones.

First, given what you've gone through in this entire process, what jurisdictional changes would you recommend to improve the rollout of a vaccine nationally when addressing a pandemic?

Second, are there any deleterious health effects from squalene in the adjuvanted vaccine?

Lastly, do we have enough stockpiled meds to keep patients intubated in the ICU in the case of a larger peak that may be forthcoming?

Thank you.